FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
Oppenheimer analyst Steven M. Lichtman upgraded AngioDynamics (NASDAQ: ANGO) from Perform to Outperform with a price target of $12.00.
The analyst comments "We are upgrading ANGO shares from Perform to Outperform with a $12 PT based on the following: 1) Yesterday's earlier than expected FDA approval... More

